Impact of impaired fasting glucose and impaired glucose tolerance on arterial stiffness in an older Chinese population: the Guangzhou Biobank Cohort Study-CVD

Metabolism: Clinical and Experimental

Volumn 59, Issue 3, 2010, Pages 367-372

  Xu, Lin ^a,b   Jiang, Chao Qiang ^a   Lam, Tai Hing ^b   Cheng, Kar Keung ^c   Yue, Xiao Jun ^a   Lin, Jie Ming ^a   Zhang, Wei Sen ^a   Thomas, G Neil ^c  

^a Guangzhou No 12 Hospital   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Public Health Laboratory   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERIAL STIFFNESS; ARTICLE; BLOOD SAMPLING; BRACHIAL ARTERY; CHINESE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE;

AGED; ANKLE BRACHIAL INDEX; ARTERIES; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHINA; COHORT STUDIES; DIABETES MELLITUS; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; LIFE STYLE; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS;

EID: 76249122883     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.08.004     Document Type: Article

References (35)

1. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 (1998) 1414-1431
2. Boutayeb A., and Boutayeb S. The burden of non communicable diseases in developing countries. Int J Equity Health 4 (2005) 2
3. Wat N.M., Lam T.H., Janus E.D., and Lam K.S. Central obesity predicts the worsening of glycemia in southern Chinese. Int J Obes Relat Metab Disord. 25 (2001) 1789-1793
4. de Vegt F., Dekker J.M., and Jager A. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population. The Hoorn Study. JAMA 285 (2001) 2109-2113
5. Tominaga M., Eguchi H., Manaka H., Igarashi K., Kato T., and Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care. 22 (1999) 920-924
6. Hanefeld M., Temelkova-Kurktschiev T., Schaper F., Henkel E., Siegert G., and Koehler C. Impaired fasting glucose is not a risk factor for atherosclerosis. Diabet Med. 16 (1999) 212-218
7. Hanefeld M., Koehler C., Fuecker K., Henkel E., Schaper F., and Temelkova-Kurktschiev T. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care. 26 (2003) 868-874
8. Festa A., D'Agostino Jr. R., Hanley A.J., Karter A.J., Saad M.F., and Haffner S.M. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes. 53 (2004) 1549-1555
9. Hong J., Gui M.H., Gu W.Q., et al. Differences in insulin resistance and pancreatic B-cell function in obese subjects with isolated impaired glucose tolerance and isolated impaired fasting glucose. Diabet Med. 25 (2008) 73-79
10. Gu D., Reynolds K., Duan X., et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia. 46 (2003) 1190-1198
11. Thomas G.N., Schooling C.M., Mc Ghee S.M., et al. Identification of factors differentially associated with isolated impaired fasting glucose and isolated post-load impaired glucose tolerance: the Hong Kong Cardiovascular Risk Factor Study. Eur J Endocrinol. 155 (2006) 623-632
12. Jiang C., Thomas G.N., Lam T.H., et al. Cohort profile: the Guangzhou Biobank Cohort Study, a Guangzhou-Hong Kong-Birmingham collaboration. Int J Epidemiol. 35 (2006) 844-852
13. Jiang C.Q., Lam T.H., Lin J.M., Liu B., Yue X.J., Cheng K.K., et al. An overview of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Subcohort (GBCS-CVD): a platform for multidisciplinary collaboration. J Hum Hypertens (2009)
14. Deng H.B., Macfarlane D.J., Thomas G.N., et al. Reliability and validity of the IPAQ-Chinese: the Guangzhou Biobank Cohort study. Med Sci Sports Exerc. 40 (2008) 303-307
15. Diagnosis and classification of diabetes mellitus. Diabetes Care 31 Suppl 1 (2008) S55-S60
16. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28 (1985) 412-419
17. Standards of medical care in diabetes-2008. Diabetes Care 31 Suppl 1 (2008) S12-S54
18. Thomas G.N., Chook P., Qiao M., et al. Deleterious impact of "high normal" glucose levels and other metabolic syndrome components on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: the CATHAY study. Arterioscler Thromb Vasc Biol. 24 (2004) 739-743
19. Thomas G.N., McGhee S.M., Schooling C.M., et al. Determinants of normoglycemia and contribution to cardiovascular risk factors in a Chinese population: the Hong Kong Cardiovascular Risk Factor Study. J Endocrinol Invest. 29 (2006) 528-535
20. Davies M.J., Raymond N.T., Day J.L., Hales C.N., and Burden A.C. Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. Diabet Med 17 (2000) 433-440
21. Abdul-Ghani M.A., Tripathy D., and DeFronzo R.A. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29 (2006) 1130-1139
22. McCance D.R., Hanson R.L., Charles M.A., et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 308 (1994) 1323-1328
23. 1c and indices of glucose tolerance derived from a standardized meal test in newly diagnosed treatment naive subjects with type 2 diabetes. Diabet Med 23 (2006) 990-995
24. Tripathy D., Carlsson M., Almgren P., et al. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes 49 (2000) 975-980
25. Weyer C., Bogardus C., and Pratley R.E. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 48 (1999) 2197-2203
26. Dowse G.K., Qin H., Collins V.R., Zimmet P.Z., Alberti K.G., and Gareeboo H. Determinants of estimated insulin resistance and beta-cell function in Indian, Creole and Chinese Mauritians. The Mauritius NCD Study Group. Diabetes Res Clin Pract 10 (1990) 265-279
27. Lind L., Vessby B., and Sundstrom J. The apolipoprotein B/AI ratio and the metabolic syndrome independently predict risk for myocardial infarction in middle-aged men. Arterioscler Thromb Vasc Biol. 26 (2006) 406-410
28. Nakagami T. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia. 47 (2004) 385-394
29. Unwin N., Shaw J., Zimmet P., and Alberti K.G. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 19 (2002) 708-723
30. Blake D.R., Meigs J.B., Muller D.C., Najjar S.S., Andres R., and Nathan D.M. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. Diabetes. 53 (2004) 2095-2100
31. Yu W.C., Chuang S.Y., Lin Y.P., and Chen C.H. Brachial-ankle vs carotid-femoral pulse wave velocity as a determinant of cardiovascular structure and function. J Hum Hypertens. 22 (2008) 24-31
32. Matsumoto M., Inoue K., and Moriki A. Associations of brachial-ankle pulse wave velocity and carotid atherosclerotic lesions with silent cerebral lesions. Hypertens Res 30 (2007) 767-773
33. Yki-Jarvinen H., and Westerbacka J. Insulin resistance, arterial stiffness and wave reflection. Adv Cardiol. 44 (2007) 252-260
34. Cruickshank K., Riste L., Anderson S.G., Wright J.S., Dunn G., and Gosling R.G. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?. Circulation. 106 (2002) 2085-2090
35. Laurent S., Cockcroft J., Van Bortel L., et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 27 (2006) 2588-2605